Supplementary Table S3 from Clinical and Genomic Predictors of Adverse Events in Newly Diagnosed Glioblastoma

Supplemental Table 3A: Univariate analysis of molecular alterations associated with seizure at diagnosis showing significant genes at a nominal p<0.05. Genes associated with seizures at a false discovery rate (FDR) <0.2 were tested in multivariable analyses (see Supplemental Table 4).